ASCLS eNewsBytes

This message was sent to ##Email##

March 15, 2016

Subscribe | Archive | Advertise

Search Archive | View Web Version | Advertise

Search Past Issues

View Web Version

Advertise

CDC flu update: Number of states reporting widespread activity increased from 33 to 37

Centers for Disease Control and Prevention via Infection Control Today
According to the recent FluView report from the Centers for Disease Control and Prevention, flu activity increased in the United States. Influenza-like-illness levels climbed, and the number of states reporting widespread flu activity increased from 33 to 37. READ MORE

Sleep apnea may drive tumor growth by promoting blood vessel formation

Medical News Today
A new study sheds light on how sleep apnea might worsen outcomes for cancer patients, revealing that hypoxia — a consequence of the sleep disorder — may promote blood vessel growth in tumors. READ MORE

Genetic tests and precision medicine start to win acceptance by some payers; pathologists and clinical laboratories have opportunity as advisers

DARK Daily
Studies showing success of targeted therapies in cancer care may be having an influence on the decisions by certain health insurers to reimburse clinical laboratories for certain genetic tests. One example that press reports cite is how last December UnitedHealthcare began reimbursing for a certain genetic test for patients with a particular lung cancer, according to a statement from Foundation Medicine. READ MORE

SPONSORED CONTENT

Promoted by
ABX Pentra 400 Pass your tests with flying colors... Pentra DX Nexus SPS with Multilink: Process efficiency in Hematology... Integration and Flexibility.... ABX Pentra XL80 Delivering the performance and efficiency you need from a Hematology analyzer... ABX Micros CRP 200: The power of Synergy; C-reactive Protein and Complete Blood count together... ABX Micros 60 Hematology analyzer utilizing Data management with the LiteDM, Simple navigation and reporting...

Breast cancer drug combination could shrink tumors in days

Drug Discovery & Development
A combination of breast cancer drugs administered before surgery could drastically shrink particular tumors within days — and potentially eliminate the need for chemotherapy in some patients, according to British researchers. Herceptin in concert with lapatinib on tumors that are HER-2 positive can shrink or even destroy tumors within just 11 days before surgery, according to The Institute of Cancer Research in London. READ MORE

PRODUCT SHOWCASE

Is your lab InspectionProof?

With MediaLab's InspectionProof, your lab is ready for an inspection, no matter when it happens. Upload inspection checklists and provide responses in our easy to use web-based system. Delegate checklist items to supervisors and lead techs. Import responses from year to year. Get an instant quote!

Highly active gene found in aggressive human lung cancer

Thomas Jefferson University via ScienceDaily
Scientists believe that "conserved" genes — those found in life forms that range from bacteria to plants, insects and humans — perform vital biological functions across species. And limited research on one of those genes, Nitrilase 1, suggested it acts to inhibit cancer development. READ MORE

Scientists find 'good' cholesterol can sometimes be bad

Reuters
So-called "good" cholesterol may actually increase heart attack risks in some people, researchers said, a discovery that casts fresh doubt on drugs designed to raise it. High density lipoprotein cholesterol is generally associated with reduced heart risks, since it usually offsets the artery-clogging effects of the low density form. READ MORE

HIV diagnosis gets simpler with affordable disposable biochip

NDTV-TV
Researchers have developed a highly sensitive disposable biosensor that can detect subpopulations' white blood cells that are key to diagnosis of HIV/AIDS. The new biosensor could not only make HIV diagnosis possible in places that lack testing facilities but also bring down the cost of the diagnosis, according to the researchers. READ MORE

PRODUCT SHOWCASE

Now Order Online!

ZeptoMetrix Corporation (ZMC) is an Industry leader and innovator identified with quality, reliable and trusted Products and Services for Infectious Disease Diagnostic Development. From assay conception to launch, our Scientific and Operational Teams provide our Customers with cohesive, inventive and cost effective solutions.
Learn More

In Zika fight, FDA gives tentative OK to tests of gene-modified mosquito

HealthDay News
U.S. health officials have given tentative approval to a field test in the Florida Keys of mosquitoes genetically tweaked to help curb the spread of the Zika virus. Officials at the U.S. Food and Drug Administration said they made the preliminary determination that the test of the genetically engineered insects poses little harm to people, animals or the environment. READ MORE

Introducing Aquios CL Flow Cytometer
It’s like having my own Flow cytometry lab at my finger tips. Finally, a simple way to bring flow cytometry CD4 testing in-house. MORE

Scientists discover a new kind of stem cell

Popular Science
There's a new stem cell in town: induced XEN, or iXEN. Scientists thought for years they were a byproduct of other developing stem cells, but researchers have now determined that they are their own type of cell with their own function, according to a study published in the journal Stem Cell Reports. READ MORE

Nicotine vaccine delays the drug's effects in mice

American Chemical Society via Lab Manager
Many people who smoke want to quit, but the urge to light up is often irresistible. An effective vaccine to help people kick the habit once and for all has been elusive. But now, scientists report in the American Chemical Society's Journal of Medicinal Chemistry a new vaccine design that could help achieve this goal. READ MORE